- Home
- PRAX vs JAMF Comparison
PRAX vs JAMF Comparison
Compare PRAX & JAMF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PRAX
- JAMF
- Stock Information
- Founded
- PRAX 2015
- JAMF 2002
- Country
- PRAX United States
- JAMF United States
- Employees
- PRAX N/A
- JAMF N/A
- Industry
- PRAX Biotechnology: Pharmaceutical Preparations
- JAMF Computer Software: Prepackaged Software
- Sector
- PRAX Health Care
- JAMF Technology
- Exchange
- PRAX Nasdaq
- JAMF Nasdaq
- Market Cap
- PRAX 950.8M
- JAMF 1.1B
- IPO Year
- PRAX 2020
- JAMF 2020
- Fundamental
- Price
- PRAX $47.08
- JAMF $8.39
- Analyst Decision
- PRAX Strong Buy
- JAMF Buy
- Analyst Count
- PRAX 10
- JAMF 11
- Target Price
- PRAX $102.00
- JAMF $16.64
- AVG Volume (30 Days)
- PRAX 578.2K
- JAMF 1.6M
- Earning Date
- PRAX 08-04-2025
- JAMF 08-07-2025
- Dividend Yield
- PRAX N/A
- JAMF N/A
- EPS Growth
- PRAX N/A
- JAMF N/A
- EPS
- PRAX N/A
- JAMF N/A
- Revenue
- PRAX $7,765,000.00
- JAMF $666,382,000.00
- Revenue This Year
- PRAX N/A
- JAMF $12.65
- Revenue Next Year
- PRAX $3,567.38
- JAMF $9.02
- P/E Ratio
- PRAX N/A
- JAMF N/A
- Revenue Growth
- PRAX 338.45
- JAMF 11.36
- 52 Week Low
- PRAX $26.70
- JAMF $7.09
- 52 Week High
- PRAX $91.83
- JAMF $18.99
- Technical
- Relative Strength Index (RSI)
- PRAX 42.83
- JAMF 52.97
- Support Level
- PRAX $44.25
- JAMF $7.83
- Resistance Level
- PRAX $49.97
- JAMF $8.70
- Average True Range (ATR)
- PRAX 3.36
- JAMF 0.39
- MACD
- PRAX -0.89
- JAMF 0.16
- Stochastic Oscillator
- PRAX 18.84
- JAMF 72.30
About PRAX Praxis Precision Medicines Inc.
Praxis Precision Medicines Inc is a clinical-stage biopharmaceutical company. The firm is engaged in translating genetic insights into the development of therapies for patients affected by central nervous system disorders characterized by a neuronal excitation-inhibition imbalance. The company has generated three clinical-stage product candidates, ulixacaltamide (formerly known as PRAX-944), vormatrigine (formerly known as PRAX-628), and relutrigine (formerly known as PRAX-562), as well as PRAX-020 which has been in-licensed by UCB Biopharma SRL, or UCB.
About JAMF Jamf Holding Corp.
Jamf Holding Corp is the standard in Apple Enterprise Management, and its cloud software platform is the vertically focused Apple infrastructure and security platform. The company helps organizations, including businesses, hospitals, schools, and government agencies, connect, manage, and protect Apple products, apps, and corporate resources in the cloud without ever having to touch the devices. It sells its Software-as-a-Service, or SaaS, solutions via a subscription model, through a direct sales force, online, and indirectly via its channel partners, including Apple. The company operates in The Americas; Europe, the Middle East, India, and Africa; and Asia Pacific.